Viewing Study NCT01016366


Ignite Creation Date: 2025-12-24 @ 4:41 PM
Ignite Modification Date: 2025-12-26 @ 10:47 PM
Study NCT ID: NCT01016366
Status: COMPLETED
Last Update Posted: 2016-11-08
First Post: 2009-11-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of Carbamylated Erythropoietin to Treat Patients With the Neurodegenerative Disorder Friedreich's Ataxia
Sponsor: H. Lundbeck A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module